Read / Add Comments
With the first round of Pfizer’s COVID-19 vaccine set to be distributed potentially as soon as this weekend, a new interactive website has been launched that will answer any questions that one may have about the vaccination process.
“COVID Vaccine Facts” has been set up by the Washington D.C.-based Biotechnology Innovation Organization (BIO) to help educate the public about the vaccine before it is shipped out by the federal government.
“The content on this website serves as an educational tool to link people to third-party scientific and evidenced-based information related to the vaccine development process, along with the safety, efficacy, availability, and affordability of COVID-19 vaccines,” according to BIO.
Originally published on December 18, 2020 6:55 pm
Hungarian-born scientist Katalin Karikó believed in the potential of messenger RNA the genetic molecule at the heart of two new COVID-19 vaccines even when almost no one else did.
Karikó began working with RNA as a student in Hungary. When funding for her job there ran out, Kariko immigrated to Philadelphia in 1985. Over the years, she s been rejected for grant after grant, threatened with deportation and demoted from her faculty job by a university that saw her research as a dead end.
Through it all, Karikó just kept working.
If new COVID-19 vaccines help life in the U.S. get back to normal next year, the nation will have many immigrants such as Karikó to thank. Scientists and investors born outside the U.S. played crucial roles in the development of vaccines from Pfizer and Moderna. It s a remarkable vindication for the argument often made by the biotech industry that innovation depends on the free movement of pe
By |
December 18, 2020
Hungarian-born scientist Katalin Karikó believed in the potential of messenger RNA the genetic molecule at the heart of two new COVID-19 vaccines even when almost no one else did.
Karikó began working with RNA as a student in Hungary. When funding for her job there ran out, Kariko immigrated to Philadelphia in 1985. Over the years, she’s been rejected for grant after grant, threatened with deportation and demoted from her faculty job by a university that saw her research as a dead end.
Through it all, Karikó just kept working.
If new COVID-19 vaccines help life in the U.S. get back to normal next year, the nation will have many immigrants like Karikó to thank. Scientists and investors born outside of the U.S. played crucial roles in the development of vaccines from Pfizer and Moderna. It’s a remarkable vindication for the argument often made by the biotech industry that innovation depends on the free movement of people and ideas.
Coons’ bipartisan bill to promote sustainable chemistry to become law
Delaware News Desk
The fiscal 2021 National Defense Authorization Act that passed the Senate on Dec. 11 includes the bipartisan Sustainable Chemistry Research and Development Act of 2019, led by Sen. Chris Coons, D-Delaware, and cosponsored by Sens. Susan Collins, R-Maine; Amy Klobuchar, D-Minnesota; and Shelley Moore Capito, R-West Virginia.
The bill will support American manufacturing and American jobs while also protecting human health and the environment by helping to realize the full innovation and market potential of sustainable chemistry technologies.
“The chemical sector is an integral part of Delaware’s economy, and I am proud that this legislation will support green chemistry innovation, create new companies and jobs and promote sustainable use of resources,” said Coons. “By creating a cohesive national vision for sustainable chemistry research and development, improving training of chemis
Originally published on December 18, 2020 5:55 pm
Hungarian-born scientist Katalin Karikó believed in the potential of messenger RNA the genetic molecule at the heart of two new COVID-19 vaccines even when almost no one else did.
Karikó began working with RNA as a student in Hungary. When funding for her job there ran out, Kariko immigrated to Philadelphia in 1985. Over the years, she s been rejected for grant after grant, threatened with deportation and demoted from her faculty job by a university that saw her research as a dead end.
Through it all, Karikó just kept working.
If new COVID-19 vaccines help life in the U.S. get back to normal next year, the nation will have many immigrants such as Karikó to thank. Scientists and investors born outside the U.S. played crucial roles in the development of vaccines from Pfizer and Moderna. It s a remarkable vindication for the argument often made by the biotech industry that innovation depends on the free movement of pe